Showing results (71-80 of 535) with videos related to
Sort By:
Pageof 54
Molecular Cancer Therapeutics|December 17, 2008
Combination of antiangiogenesis with chemotherapy for more effective cancer treatmentJie Ma, David J WaxmanPlos One|December 2, 2020
Genetic factors contributing to extensive variability of sex-specific hepatic gene expression in Diversity Outbred miceTisha Melia, David J WaxmanCancer Letters|February 8, 2018
Immunogenic chemotherapy: Dose and schedule dependence and combination with immunotherapyJunjie Wu, David J WaxmanToxicology in Vitro : an International Journal Published in Association with BIBRA|November 19, 2005
Activation of oxazaphosphorines by cytochrome P450: application to gene-directed enzyme prodrug therapy for cancerPartha Roy, David J WaxmanToxicology and Applied Pharmacology|May 12, 2023
TCDD dysregulation of lncRNA expression, liver zonation and intercellular communication across the liver lobuleKritika Karri, David J WaxmanArchives of Biochemistry and Biophysics|August 1, 1987
Human liver folylpolyglutamate synthetase: biochemical characterization and interactions with folates and folate antagonistsL Clarke, D J WaxmanCancer Research|May 1, 1989
Oxidative metabolism of cyclophosphamide: identification of the hepatic monooxygenase catalysts of drug activationL Clarke, D J WaxmanCancer Surveys|January 1, 1995
Multiple primary cancers in association with prostate cancerH S Pandha, J WaxmanCancer Research|June 5, 2001
Frequent, moderate-dose cyclophosphamide administration improves the efficacy of cytochrome P-450/cytochrome P-450 reductase-based cancer gene therapyY Jounaidi, D J WaxmanCancer Letters|November 26, 2019
Medium dose intermittent cyclophosphamide induces immunogenic cell death and cancer cell autonomous type I interferon production in glioma modelsBin Du, David J WaxmanPageof 54